Saturday, December 12, 2020 5:08:48 PM
TACL-T2012-002: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
https://www.texaschildrens.org/https%3A/clinicaltrials.gov/ct2/results/browse%3Fterm%3DTexas%2BChildren%2527s%2BHospital%26recr%3DOpen%26state1%3DNA%253AUS%253ATX%26brwse%3Dcond_alpha_all/tacl-t2012-002-vincristine-sulfate-liposome-injection-marqibo%C2%AE
Sponsor:
Therapeutic Advances in Childhood Leukemia Consortium
Collaborator:
Spectrum Pharmaceuticals, Inc
https://clinicaltrials.gov/ct2/show/NCT02879643?term=T2012&rank=1
Recent SPPI News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 11/09/2023 10:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:27 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 09:23:08 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM